Xencor XNCR
NASDAQ XNCR
$26.61 -0.01 (-0.04%)
As of: Sep 4, 2026 · 3:59 PM EDT

Xencor (XNCR) Capital Expenditures (2013 - 2026)

Xencor (XNCR) posted quarterly Capital Expenditures of $610000.0 for Q1 2026, down 57.76% year-over-year from $1.4 million in Q1 2025, and down 46.49% quarter-over-quarter from $1.1 million in Q4 2025.

Analysis

Xencor (XNCR) Capital Expenditures (2013 - 2026) Analysis & Trends

Xencor (XNCR) has reported Capital Expenditures for 14 consecutive years, with $610000.0 the latest figure, recorded in Q1 2026.

  • In Q1 2026, Capital Expenditures fell 57.76% year-over-year to $610000.0; the TTM figure through Mar 2026 stood at $2.3 million (down 68.74% YoY), while the FY2025 annual figure was $3.2 million, down 48.34% from the prior year.
  • Capital Expenditures fell to $610000.0 in Q1 2026 per XNCR's latest filing, from $1.1 million in the prior quarter.
  • Across five years, Capital Expenditures topped out at $14.1 million in Q3 2022 and bottomed at $132000.0 in Q1 2024.
  • Historically, Capital Expenditures has averaged $3.9 million across 5 years, with a median of $1.7 million in 2024.
  • Annual changes were most pronounced in 2024 — Capital Expenditures slumped 98.78% — and 2025, when it jumped 993.94%.
  • Xencor's Capital Expenditures stood at $10.0 million in 2022, then plunged by 90.17% to $980000.0 in 2023, then surged by 69.8% to $1.7 million in 2024, then tumbled by 31.49% to $1.1 million in 2025, then plunged by 46.49% to $610000.0 in 2026.
  • Business Quant data shows XNCR's Capital Expenditures at $610000.0 in Q1 2026, $1.1 million in Q4 2025, and $183000.0 in Q3 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Capital Expenditures (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn 112.20 Mn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 240.20 Mn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn -
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn 37.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn - 2.29 Mn
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 25.02 Mn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn 34.68 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn - 251.02 Mn
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn 6.26 Mn
10 Xencor 2.02 Bn 1.65 Bn - 538,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 538,000.00
Mar 31, 2026 610,000.00
Dec 31, 2025 1.14 Mn
Sep 30, 2025 183,000.00
Jun 30, 2025 383,000.00
Mar 31, 2025 1.44 Mn
Dec 31, 2024 1.66 Mn
Sep 30, 2024 1.28 Mn
Jun 30, 2024 3.03 Mn
Mar 31, 2024 132,000.00
Dec 31, 2023 980,000.00
Sep 30, 2023 2.83 Mn
Jun 30, 2023 3.85 Mn
Mar 31, 2023 10.78 Mn
Dec 31, 2022 9.97 Mn
Sep 30, 2022 14.09 Mn
Jun 30, 2022 12.35 Mn
Mar 31, 2022 2.09 Mn
Dec 31, 2021 6.32 Mn
Sep 30, 2021 2.75 Mn